Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Journal of Neurovirology|September 2, 2015
Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trialAlejandro Arenas-Pinto, Jennifer Thompson, Godfrey Musoro, et al.
AIDS (London, England)|February 1, 2023
Impact of sub-optimal HIV viral control on activated T cellsFrancesca I F Arrigoni, Moira Spyer, Patricia Hunter, et al.
AIDS (London, England)|July 27, 2016
Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapyWolfgang Stöhr, David T Dunn, Alejandro Arenas-Pinto, et al.
Journal of Clinical Microbiology|November 6, 2004
Characterization of ancestral Mycobacterium tuberculosis by multiple genetic markers and proposal of genotyping strategyYong-Jiang Sun, Ann S G Lee, Sze Ta Ng, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Coadministration of Allopurinol To Increase Antimycobacterial Efficacy of Pyrazinamide as Evaluated in a Whole-Blood Bactericidal Activity ModelClaire M Naftalin, Rupangi Verma, Meera Gurumurthy, et al.
Viruses|January 26, 2024
Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT TrialAnna L Schuldt, Henry Bern, Melanie Hart, et al.
Emerging Infectious Diseases|June 5, 2003
Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contactsLi-Yang Hsu, Cheng-Chuan Lee, Justin A Green, et al.
BMC Infectious Diseases|June 11, 2020
A blood RNA transcript signature for TB exposure in household contactsPhilip Kam Weng Kwan, Balamurugan Periaswamy, Paola Florez De Sessions, et al.
Plos Medicine|October 24, 2008
Inflammatory and coagulation biomarkers and mortality in patients with HIV infectionLewis H Kuller, Russell Tracy, Waldo Belloso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized TrialJennifer A Thompson, Cissy Kityo, David Dunn, et al.
Pageof 10